1. Home
  2. RGS vs IOBT Comparison

RGS vs IOBT Comparison

Compare RGS & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$22.00

Market Cap

66.3M

ML Signal

HOLD

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.36

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGS
IOBT
Founded
1922
2014
Country
United States
Denmark
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
57.2M
IPO Year
1991
2021

Fundamental Metrics

Financial Performance
Metric
RGS
IOBT
Price
$22.00
$0.36
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.25
AVG Volume (30 Days)
14.5K
28.1M
Earning Date
02-05-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
0.41
N/A
EPS
40.63
N/A
Revenue
$233,430,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.54
N/A
Revenue Growth
22.00
N/A
52 Week Low
$15.00
$0.21
52 Week High
$31.50
$2.79

Technical Indicators

Market Signals
Indicator
RGS
IOBT
Relative Strength Index (RSI) 33.78 45.08
Support Level $21.49 $0.32
Resistance Level $23.00 $0.40
Average True Range (ATR) 0.90 0.04
MACD -0.03 0.02
Stochastic Oscillator 14.17 76.55

Price Performance

Historical Comparison
RGS
IOBT

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: